Next Article in Journal
Calcium Signalling in Plant Biotic Interactions
Previous Article in Journal
Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles
Review

Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials

1
Nephrology Service, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), University Hospital Reina Sofía, University of Córdoba, 14004 Córdoba, Spain
2
Red de Investigación Renal (REDinREN), Instituto de Salud Carlos III, 28029 Madrid, Spain
*
Author to whom correspondence should be addressed.
Both authors share first authorship.
Int. J. Mol. Sci. 2018, 19(3), 664; https://doi.org/10.3390/ijms19030664
Received: 9 January 2018 / Revised: 12 February 2018 / Accepted: 21 February 2018 / Published: 27 February 2018
(This article belongs to the Section Molecular Toxicology)
Patients with advanced chronic kidney disease exhibit an increase in cardiovascular mortality. Recent works have shown that low levels of magnesium are associated with increased cardiovascular and all-cause mortality in hemodialysis patients. Epidemiological studies suggest an influence of low levels of magnesium on the occurrence of cardiovascular disease, which is also observed in the normal population. Magnesium is involved in critical cellular events such as apoptosis and oxidative stress. It also participates in a number of enzymatic reactions. In animal models of uremia, dietary supplementation of magnesium reduces vascular calcifications and mortality; in vitro, an increase of magnesium concentration decreases osteogenic transdifferentiation of vascular smooth muscle cells. Therefore, it may be appropriate to evaluate whether magnesium replacement should be administered in an attempt to reduce vascular damage and mortality in the uremic population In the present manuscript, we will review the magnesium homeostasis, the involvement of magnesium in enzymatic reactions, apoptosis and oxidative stress and the clinical association between magnesium and cardiovascular disease in the general population and in the context of chronic kidney disease. We will also analyze the role of magnesium on kidney function. Finally, the experimental evidence of the beneficial effects of magnesium replacement in chronic kidney disease will be thoroughly described. View Full-Text
Keywords: magnesium; chronic kidney disease; cardiovascular disease; vascular calcification; mortality magnesium; chronic kidney disease; cardiovascular disease; vascular calcification; mortality
Show Figures

Graphical abstract

MDPI and ACS Style

Muñoz-Castañeda, J.R.; Pendón-Ruiz de Mier, M.V.; Rodríguez, M.; Rodríguez-Ortiz, M.E. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials. Int. J. Mol. Sci. 2018, 19, 664. https://doi.org/10.3390/ijms19030664

AMA Style

Muñoz-Castañeda JR, Pendón-Ruiz de Mier MV, Rodríguez M, Rodríguez-Ortiz ME. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials. International Journal of Molecular Sciences. 2018; 19(3):664. https://doi.org/10.3390/ijms19030664

Chicago/Turabian Style

Muñoz-Castañeda, Juan R., María V. Pendón-Ruiz de Mier, Mariano Rodríguez, and María E. Rodríguez-Ortiz. 2018. "Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials" International Journal of Molecular Sciences 19, no. 3: 664. https://doi.org/10.3390/ijms19030664

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop